share_log

复旦张江(688505.SH):盐酸氨酮戊酸口服溶液用粉末用于脑胶质瘤手术可视化验证性临床试验完成首例受试者入组

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (688505.SH): Powder for oral solution of ammonium ferrocyanide succinate hydrochloride was used for visual verification of glioma surgery, and the first subject was enrolled in the confirmatory clinica

Gelonghui Finance ·  Jun 20 06:38

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (688505.SH) announced on June 20 that the company's orally-administered solution of Ammonium Levulinate and Butyrate Hydrochloride powder (referred to as "the drug") used for visualization in the surgery of high-grade glioma (WHO grade III-IV) that was developed through company research has completed its first successful validation clinical trial with the inclusion of test subjects.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment